Key Takeaways
- PLTR shares declined to a 52-week bottom of $107.27 on Thursday, dropping 5.5% and suffering a 39% year-to-date loss
- The stock has plummeted 31% throughout this month, heading toward its steepest monthly decline since early 2021
- Cathie Wood’s ARK Invest acquired 30,528 shares of PLTR valued at approximately $3.3 million during Thursday’s session
- ARK simultaneously purchased $18.9M in Cerebras stock while divesting roughly $16.7M worth of Alibaba holdings
- Analyst consensus reflects an Overweight stance with a $189.87 target price, suggesting 77% potential appreciation
Palantir (PLTR) shares showed a 0.8% gain to $108.12 during Friday’s premarket trading, rebounding slightly from Thursday’s closing price of $107.27 — marking a new 52-week bottom and the seventh consecutive negative session.
Palantir Technologies Inc., PLTR
The 5.5% Thursday decline amplified an already punishing period for PLTR shareholders. The equity has surrendered 20% across the previous two weeks and 31% during this month’s trading.
Should Friday conclude with another loss, it would represent eight straight declining sessions — a streak that could establish its most severe monthly percentage contraction since dropping 32% in February 2021, according to Dow Jones Market Data.
PLTR has tumbled 39% during 2026, representing a dramatic turnaround following three consecutive years of substantial returns. By comparison, the S&P 500 has advanced 7.5% while the Nasdaq Composite has climbed 9% during the identical timeframe.
The equity now sits 48% beneath its all-time closing peak of $207.18, recorded on November 3, 2025.
Critical Technical Thresholds Breached
This past Monday, PLTR collapsed below the $127 level — a support threshold maintained since February. The stock currently trades 15% under that benchmark.
Thursday delivered another significant violation: shares penetrated below $128, representing a crucial weekly chart support level that had remained intact throughout the preceding 12 months.
The stock has also fallen substantially beneath both primary moving averages. The 50-day moving average hovers around $137, while the 200-day moving average rests near $159.
ARK Invest Seizes Opportunity
With shares at depressed levels, ARK Invest made its move. During Thursday’s session, Cathie Wood’s investment firm accumulated 30,528 PLTR shares distributed across the ARK Innovation ETF (ARKK), the ARK Next Generation Internet ETF (ARKW), and the ARK Blockchain & Fintech Innovation ETF (ARKF), totaling approximately $3.3 million.
Palantir represents 2.4%, 2.3%, and 3.7% of these three portfolios, respectively.
ARK’s activity extended beyond this purchase. The firm also accumulated 111,989 shares of Cerebras Systems (CBRS) throughout ARKK and ARKW, valued at approximately $18.9 million based on CBRS’s closing price of $168.52.
Regarding dispositions, ARK liquidated 176,004 Alibaba (BABA) shares across ARKF, ARKK, and ARKW — representing a transaction worth approximately $16.7 million. Alibaba has encountered headwinds following Anthropic’s allegations regarding AI model distillation methodologies.
ARK additionally acquired 9,014 shares of Coinbase (COIN) and purchased 891,473 shares of Recursion Pharmaceuticals (RXRX). The firm divested 130,666 shares of Roku (ROKU) and 37,555 shares of Twist Bioscience (TWST).
From a bearish perspective, Michael Burry has expressed concerns about PLTR, highlighting diminished trading volume and identifying the stock’s pattern as indicative of an extended downward trajectory.
Notwithstanding the selling pressure, Wall Street’s overall perspective on PLTR remains favorable. Among 33 firms monitored by FactSet, 17 assign it a Buy rating, three Overweight, 11 Hold, and two Sell. The consensus price target reaches $189.87 — representing a 77% upside from Thursday’s closing level.
Palantir’s Benzinga Edge Momentum score ranks in the 5th percentile, accompanied by a Value score positioned in the 2nd percentile.


